title: Myelokathexis treated with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF).
authors.affiliation: Department of Haematology, University of Frankfurt, Germany.
authors.forename: U
authors.initials: U
authors.lastname: Hess
authors.forename: A
authors.initials: A
authors.lastname: Ganser
authors.forename: H G
authors.initials: HG
authors.lastname: Schnürch
authors.forename: G
authors.initials: G
authors.lastname: Seipelt
authors.forename: O G
authors.initials: OG
authors.lastname: Ottmann
authors.forename: S
authors.initials: S
authors.lastname: Falk
authors.forename: G
authors.initials: G
authors.lastname: Schulz
authors.forename: D
authors.initials: D
authors.lastname: Hoelzer
mesh_terms: D000328:Adult; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007958:Leukocyte Count / Q000187:drug effects; D009503:Neutropenia / Q000188:drug therapy*; D055728:Primary Myelofibrosis / Q000139:chemically induced; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor